Catabasis raises $20 million follow-on

Catabasis Pharmaceuticals Inc. (NASDAQ:CATB) raised $20 million on Feb. 6 in a follow-on on through the sale of four million units at $5. The price is a 17% discount to the endocrine and metabolic company's close of $6.05 on Feb. 5. Each unit comprises a share and a five-year warrant to purchase 0.5 additional shares, with each whole warrant exercisable at $6.25...